Last reviewed · How we verify
NCT01041911
Double-blind, Randomized, Placebo-controlled, Dose Response Study to Evaluate the Safety and Efficacy of Three Doses of Euphorbia Prostrata Dry Extract Tablets in Patients of Hemorrhoids
Phase 2 trial testing Euphorbia tablets in Hemorrhoids in 102 participants. Completed in 1 November 2010.
1 October 2010
Quick facts
| Lead sponsor | Panacea Biotec Ltd |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 102 |
| Start date | 1 March 2010 |
| Primary completion | 1 October 2010 |
| Estimated completion | 1 November 2010 |
| Sites | 6 locations across India |
Drugs / interventions tested
- Euphorbia tablets — full drug profile →
- Euphorbia tablets — full drug profile →
- Euphorbia tablets — full drug profile →
- Placebo tablets — full drug profile →
Conditions studied
- Hemorrhoids — all drugs for Hemorrhoids →
Sponsor
Panacea Biotec Ltd — full company profile →
Who can join
18 and older, any sex, with Hemorrhoids. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Proportion of subjects in each treatment group achieving cessation of per rectal bleeding as assessed by the subject
Time frame: 14 day of treatment
Sponsor's own description
The purpose of this study is to determine the safe and efficacious dose of Euphorbia prostrata for control of per rectal bleeding in patients with first and second degree hemorrhoids.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
<i>Euphorbia</i>-Derived Natural Products with Potential for Use in Health Maintenance.
Salehi B, Iriti M, Vitalini S, Antolak H, et al · · 2019 · cited 54× · PMID 31382529 · DOI 10.3390/biom9080337
Verify or expand the search:
- PubMed search for NCT01041911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemorrhoids
Currently open trials in the same condition.
- NCT07350460 — PUSHES (Pudendal Block Versus Sacral ESP Hemorrhoidectomy Study) · NA · recruiting
- NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
- NCT05782010 — SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids · NA · recruiting
- NCT05697562 — Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease · NA · recruiting
- NCT03972956 — Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01041911 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Panacea Biotec Ltd
- Last refreshed: 4 December 2012
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01041911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing